ASLN Annual CFO
-$46.64 M
-$8.23 M-21.44%
31 December 2023
Summary:
As of January 29, 2025, ASLN annual cash flow from operations is -$46.64 million, with the most recent change of -$8.23 million (-21.44%) on December 31, 2023. During the last 3 years, it has fallen by -$31.59 million (-209.83%).ASLN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASLN Quarterly CFO
N/A
31 March 2024
Summary:
ASLN quarterly cash flow from operations is not available.ASLN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASLN TTM CFO
N/A
31 March 2024
Summary:
ASLN TTM cash flow from operations is not available.ASLN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASLN Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.4% | - | - |
| 3 y3 years | -209.8% | - | - |
| 5 y5 years | -18.2% | - | - |
ASLN Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +705.6% |
ASLAN Pharmaceuticals Limited Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$46.64 M(+21.4%) | - | - |
| Dec 2022 | -$38.41 M(+13.0%) | - | - |
| Dec 2021 | -$34.00 M(+125.8%) | - | - |
| Dec 2020 | -$15.05 M(-41.7%) | - | - |
| Dec 2019 | -$25.80 M(-34.6%) | - | - |
| Dec 2018 | -$39.47 M(+15.7%) | - | - |
| Dec 2018 | - | -$9.65 M(-8.2%) | -$39.47 M(-1.5%) |
| Sept 2018 | - | -$10.52 M(+13.9%) | -$40.06 M(+4.4%) |
| June 2018 | - | -$9.24 M(-8.2%) | -$38.36 M(+0.7%) |
| Mar 2018 | - | -$10.06 M(-1.8%) | -$38.10 M(+11.7%) |
| Dec 2017 | -$34.12 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | - | -$10.24 M(+16.1%) | -$34.12 M(+17.0%) |
| Sept 2017 | - | -$8.82 M(-1.7%) | -$29.15 M(+108.3%) |
| June 2017 | - | -$8.97 M(+47.7%) | -$13.99 M(+78.7%) |
| Mar 2017 | - | -$6.08 M(+15.2%) | -$7.83 M(+35.3%) |
| Dec 2016 | -$5.79 M(-47.6%) | - | - |
| Dec 2016 | - | -$5.28 M(-183.3%) | -$5.79 M(+1029.6%) |
| Sept 2016 | - | $6.33 M(-325.3%) | -$512.50 K(-92.5%) |
| June 2016 | - | -$2.81 M(-30.4%) | -$6.85 M(+69.6%) |
| Mar 2016 | - | -$4.04 M | -$4.04 M |
| Dec 2015 | -$11.06 M(+76.0%) | - | - |
| Dec 2014 | -$6.28 M | - | - |
FAQ
- What is ASLAN Pharmaceuticals Limited annual cash flow from operations?
- What is the all time high annual CFO for ASLAN Pharmaceuticals Limited?
- What is ASLAN Pharmaceuticals Limited annual CFO year-on-year change?
- What is the all time high quarterly CFO for ASLAN Pharmaceuticals Limited?
- What is the all time high TTM CFO for ASLAN Pharmaceuticals Limited?
What is ASLAN Pharmaceuticals Limited annual cash flow from operations?
The current annual CFO of ASLN is -$46.64 M
What is the all time high annual CFO for ASLAN Pharmaceuticals Limited?
ASLAN Pharmaceuticals Limited all-time high annual cash flow from operations is -$5.79 M
What is ASLAN Pharmaceuticals Limited annual CFO year-on-year change?
Over the past year, ASLN annual cash flow from operations has changed by -$8.23 M (-21.44%)
What is the all time high quarterly CFO for ASLAN Pharmaceuticals Limited?
ASLAN Pharmaceuticals Limited all-time high quarterly cash flow from operations is $6.33 M
What is the all time high TTM CFO for ASLAN Pharmaceuticals Limited?
ASLAN Pharmaceuticals Limited all-time high TTM cash flow from operations is -$512.50 K